Update: 03.08.2022
Last week: 29 week 2022 (18.07.2022 - 24.07.2022)
Last full month: June 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 105 008 | 3.5% | 6.1% | -0.2 | 20 420 252 | 3.0% | 5.6% | -0.1 | 6.7% |
| MoM | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| YTD | 6 403 496 | 24.3% | 6.0% | 0.6 | 1 265 194 490 | 47.4% | 5.7% | 0.9 | 11.8% |
| MAT | 14 521 620 | 45.0% | 6.6% | 1.6 | 2 697 263 536 | 70.8% | 6.2% | 1.7 | 10.0% |
| DEXALGIN | |||||||||
| WoW | 26 211 | -0.0% | 0.7% | 0 | 11 245 235 | 1.1% | 1.8% | 0 | 3.8% |
| MoM | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| YTD | 1 145 514 | 27.1% | 0.8% | 0.1 | 474 819 014 | 38.8% | 2.1% | 0.3 | 7.6% |
| MAT | 2 082 883 | 9.8% | 0.8% | 0 | 833 696 141 | 18.2% | 2.1% | 0.1 | 3.9% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 71 299 | -0.8% | 55.6% | -0.9 | 36 232 182 | -0.1% | 61.4% | -0.1 | 0.9% |
| MoM | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| YTD | 2 949 077 | 6.5% | 58.5% | -8.1 | 1 487 425 851 | 20.1% | 64.0% | -6.1 | 21.1% |
| MAT | 5 460 533 | 9.3% | 61.4% | -4.7 | 2 673 418 510 | 24.3% | 66.8% | -3.2 | 17.7% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 028 | 3.9% | 37.7% | -0.2 | 14 672 002 | 4.7% | 50.6% | -0.1 | 4.4% |
| MoM | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| YTD | 880 716 | -5.0% | 39.0% | -2.9 | 542 637 146 | 1.5% | 52.4% | -4.5 | 2.2% |
| MAT | 1 616 956 | -7.6% | 39.7% | -1.4 | 979 466 071 | 1.4% | 53.6% | -1.3 | -4.4% |
| FASTUM | |||||||||
| WoW | 15 906 | 2.3% | 1.0% | 0 | 8 382 224 | 2.6% | 2.3% | 0 | 6.0% |
| MoM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| YTD | 677 286 | -12.8% | 1.2% | -0.2 | 343 668 823 | -3.8% | 2.7% | -0.4 | 2.9% |
| MAT | 1 285 878 | -12.7% | 1.3% | -0.2 | 626 685 472 | -4.8% | 2.8% | -0.3 | 0.5% |
| IODOMARIN | |||||||||
| WoW | 48 924 | 3.1% | 21.1% | 0.2 | 9 664 436 | 1.2% | 9.5% | 0 | 2.4% |
| MoM | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| YTD | 1 696 131 | 8.1% | 18.5% | -0.1 | 342 647 358 | 16.1% | 8.5% | 0 | 8.8% |
| MAT | 3 293 412 | 20.5% | 20.4% | 2.2 | 639 806 614 | 22.1% | 9.3% | 0.7 | 7.5% |
| LIOTON | |||||||||
| WoW | 22 195 | -3.1% | 2.3% | -0.1 | 22 802 154 | -3.6% | 4.6% | 0 | 0.4% |
| MoM | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| YTD | 843 889 | -14.3% | 2.5% | -0.3 | 854 341 455 | 8.3% | 4.9% | -0.5 | -4.4% |
| MAT | 1 551 948 | -11.3% | 2.6% | -0.2 | 1 467 952 278 | 7.7% | 5.3% | -0.3 | -5.6% |
| MEZYM | |||||||||
| WoW | 289 378 | 1.1% | 27.1% | -0.8 | 44 732 355 | 0.6% | 19.5% | -0.7 | 4.3% |
| MoM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| YTD | 12 187 169 | 25.0% | 29.4% | 3.7 | 1 865 407 655 | 35.0% | 21.1% | 1.7 | 9.5% |
| MAT | 23 198 130 | 27.0% | 30.9% | 4.2 | 3 392 517 716 | 32.8% | 22.5% | 2.1 | 9.6% |
| MIG 400 | |||||||||
| WoW | 132 964 | 0.7% | 3.5% | -0.1 | 15 508 106 | 0.0% | 2.5% | 0 | 3.8% |
| MoM | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| YTD | 5 142 574 | 5.4% | 3.5% | -0.1 | 602 885 333 | 8.2% | 2.7% | -0.2 | 7.6% |
| MAT | 10 152 290 | 13.0% | 3.7% | 0.3 | 1 162 404 714 | 15.4% | 2.9% | 0.1 | 3.9% |
| PROSTAMOL | |||||||||
| WoW | 21 203 | 3.0% | 18.0% | 0.4 | 29 343 656 | 4.2% | 18.7% | 0.6 | 0.7% |
| MoM | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| YTD | 1 022 077 | -11.3% | 20.6% | -3.9 | 1 435 152 428 | -0.2% | 22.1% | -4.9 | 5.3% |
| MAT | 2 009 549 | -4.7% | 22.5% | -2 | 2 697 337 231 | 3.9% | 23.9% | -2.9 | 3.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 10 228 | 7.4% | 8.1% | 0 | 4 753 975 | 6.6% | 7.9% | 0 | 7.5% |
| MoM | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
| YTD | 742 423 | 198.0% | 9.1% | 5.7 | 345 772 454 | 188.1% | 8.8% | 5 | 10.1% |
| MAT | 1 240 064 | 114.1% | 8.0% | 3.9 | 570 617 834 | 102.4% | 7.9% | 3.1 | 10.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 403 496 | 24.3% | 6.0% | 0.6 | 1 265 194 490 | 47.4% | 5.7% | 0.9 | 11.8% |
| DEXALGIN | 1 145 514 | 27.1% | 0.8% | 0.1 | 474 819 014 | 38.8% | 2.1% | 0.3 | 7.6% |
| ESPUMISAN (ADULTS) | 2 949 077 | 6.5% | 58.5% | -8.1 | 1 487 425 851 | 20.1% | 64.0% | -6.1 | 21.1% |
| ESPUMISAN BABY | 880 716 | -5.0% | 39.0% | -2.9 | 542 637 146 | 1.5% | 52.4% | -4.5 | 2.2% |
| FASTUM | 677 286 | -12.8% | 1.2% | -0.2 | 343 668 823 | -3.8% | 2.7% | -0.4 | 2.9% |
| IODOMARIN | 1 696 131 | 8.1% | 18.5% | -0.1 | 342 647 358 | 16.1% | 8.5% | 0 | 8.8% |
| LIOTON | 843 889 | -14.3% | 2.5% | -0.3 | 854 341 455 | 8.3% | 4.9% | -0.5 | -4.4% |
| MEZYM | 12 187 169 | 25.0% | 29.4% | 3.7 | 1 865 407 655 | 35.0% | 21.1% | 1.7 | 9.5% |
| MIG 400 | 5 142 574 | 5.4% | 3.5% | -0.1 | 602 885 333 | 8.2% | 2.7% | -0.2 | 7.6% |
| PROSTAMOL | 1 022 077 | -11.3% | 20.6% | -3.9 | 1 435 152 428 | -0.2% | 22.1% | -4.9 | 5.3% |
| RESPERO MYRTOL | 742 423 | 198.0% | 9.1% | 5.7 | 345 772 454 | 188.1% | 8.8% | 5 | 10.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 521 620 | 45.0% | 6.6% | 1.6 | 2 697 263 536 | 70.8% | 6.2% | 1.7 | 10.0% |
| DEXALGIN | 2 082 883 | 9.8% | 0.8% | 0 | 833 696 141 | 18.2% | 2.1% | 0.1 | 3.9% |
| ESPUMISAN (ADULTS) | 5 460 533 | 9.3% | 61.4% | -4.7 | 2 673 418 510 | 24.3% | 66.8% | -3.2 | 17.7% |
| ESPUMISAN BABY | 1 616 956 | -7.6% | 39.7% | -1.4 | 979 466 071 | 1.4% | 53.6% | -1.3 | -4.4% |
| FASTUM | 1 285 878 | -12.7% | 1.3% | -0.2 | 626 685 472 | -4.8% | 2.8% | -0.3 | 0.5% |
| IODOMARIN | 3 293 412 | 20.5% | 20.4% | 2.2 | 639 806 614 | 22.1% | 9.3% | 0.7 | 7.5% |
| LIOTON | 1 551 948 | -11.3% | 2.6% | -0.2 | 1 467 952 278 | 7.7% | 5.3% | -0.3 | -5.6% |
| MEZYM | 23 198 130 | 27.0% | 30.9% | 4.2 | 3 392 517 716 | 32.8% | 22.5% | 2.1 | 9.6% |
| MIG 400 | 10 152 290 | 13.0% | 3.7% | 0.3 | 1 162 404 714 | 15.4% | 2.9% | 0.1 | 3.9% |
| PROSTAMOL | 2 009 549 | -4.7% | 22.5% | -2 | 2 697 337 231 | 3.9% | 23.9% | -2.9 | 3.9% |
| RESPERO MYRTOL | 1 240 064 | 114.1% | 8.0% | 3.9 | 570 617 834 | 102.4% | 7.9% | 3.1 | 10.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 105 008 | 3.5% | 6.1% | -0.2 | 20 420 252 | 3.0% | 5.6% | -0.1 | 6.7% |
| DEXALGIN | 26 211 | -0.0% | 0.7% | 0 | 11 245 235 | 1.1% | 1.8% | 0 | 3.8% |
| ESPUMISAN (ADULTS) | 71 299 | -0.8% | 55.6% | -0.9 | 36 232 182 | -0.1% | 61.4% | -0.1 | 0.9% |
| ESPUMISAN BABY | 23 028 | 3.9% | 37.7% | -0.2 | 14 672 002 | 4.7% | 50.6% | -0.1 | 4.4% |
| FASTUM | 15 906 | 2.3% | 1.0% | 0 | 8 382 224 | 2.6% | 2.3% | 0 | 6.0% |
| IODOMARIN | 48 924 | 3.1% | 21.1% | 0.2 | 9 664 436 | 1.2% | 9.5% | 0 | 2.4% |
| LIOTON | 22 195 | -3.1% | 2.3% | -0.1 | 22 802 154 | -3.6% | 4.6% | 0 | 0.4% |
| MEZYM | 289 378 | 1.1% | 27.1% | -0.8 | 44 732 355 | 0.6% | 19.5% | -0.7 | 4.3% |
| MIG 400 | 132 964 | 0.7% | 3.5% | -0.1 | 15 508 106 | 0.0% | 2.5% | 0 | 3.8% |
| PROSTAMOL | 21 203 | 3.0% | 18.0% | 0.4 | 29 343 656 | 4.2% | 18.7% | 0.6 | 0.7% |
| RESPERO MYRTOL | 10 228 | 7.4% | 8.1% | 0 | 4 753 975 | 6.6% | 7.9% | 0 | 7.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| DEXALGIN | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| ESPUMISAN (ADULTS) | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| ESPUMISAN BABY | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| FASTUM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| IODOMARIN | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| LIOTON | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| MEZYM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| MIG 400 | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| PROSTAMOL | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| RESPERO MYRTOL | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs